Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angelica Dorantes
Observed names:
A. Dorantes,
Angelica G. Dorantes,
Dorantes A
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
The University of Texas at Austin,
Universidad Nacional Autónoma de México
OpenAlex ID:
A5031717077
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
2013
·
Thomas M. Herndon
, Albert Deisseroth
, et al.
·
Clinical Cancer Research
·
265
Draft Guidance for Industry Extended-Release Solid Oral Dosage Forms
1997
·
Henry Malinowski
, Patrick Marroum
, et al.
·
Advances in experimental medicine and biology
·
150
FDA Guidance for Industry 1 Extended Release Solid Oral Dosage forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations
1997
·
Henry Malinowski
, Patrick Marroum
, et al.
·
Dissolution Technologies
·
94
PDF
Scientific and Regulatory Standards for Assessing Product Performance Using the Similarity Factor, f2
2015
·
Ruth E. Stevens
, Vivian Gray
, et al.
·
The AAPS Journal
·
70
PDF
Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm
2014
·
Glenn A. Van Buskirk
, Satish Asotra
, et al.
·
AAPS PharmSciTech
·
53
PDF
Impact of the US FDA “Biopharmaceutics Classification System” (BCS) Guidance on Global Drug Development
2017
·
Mehul U. Mehta
, Ramana S. Uppoor
, et al.
·
Molecular Pharmaceutics
·
46
Regulatory Experience with Continuous Manufacturing and Real Time Release Testing for Dissolution in New Drug Applications
2023
·
Maziar Kakhi
, Jing Li
, et al.
·
Journal of Pharmaceutical Sciences
·
23
PDF
The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference
2021
·
Blume HH
, Mehta M
, et al.
·
European Journal of Pharmaceutical Sciences
·
17
PDF
Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug Applications
2016
·
Sandra Suarez-Sharp
, Poonam R. Delvadia
, et al.
·
The AAPS Journal
·
17
PDF
Human pharmacokinetics of ethynyl estradiol 3-sulfate and 17-sulfate
1988
·
Joseph W. Goldzieher
, Gil Mileikowsky
, et al.
·
Steroids
·
16
Pharmacokinetic and Metabolic Disposition of p-Chloro-m-xylenol (PCMX) in Dogs
1992
·
Angelica Dorantes
, Salomon Stavchansky
·
Pharmaceutical Research
·
9
Modification of the U.S.P. Dissolution Method for the Analysis of Norethindrone and Ethinyl Estradiol Tablets
1994
·
Angelica Dorantes
, Salomon Stavchansky
·
Journal of Pharmaceutical Sciences
·
8
Bioequivalence study of nitrofurantoin tablets: in vitro-in vivo correlation
1986
·
Arturo A. Lopez
, Martha M. Molina
, et al.
·
International Journal of Pharmaceutics
·
4
The Cytotoxicity of p-Chloro-m-xylenol in Primary Culture of Rat Hepatocytes
1991
·
Julio C. Davila
, Angelica Dorantes
, et al.
·
Pharmaceutical Research
·
3
Determination of PCMX Conjugated Metabolites in Blood Plasma and Urine Using Enzymatic Hydrolysis and High Performance Liquid Chromatography
1991
·
A. Dorantes
, S. Stavchansky
·
Analytical Letters
·
2
High Performance Liquid Chromatography Determination of Pcmx In Blood Plasma Using Electrochemical Detection
1989
·
A. Dorantes
, S. Stavchansky
·
Analytical Letters
·
2
Disolución comparativa de formas farmacéuticas sólidas que se encuentran en el mercado farmacéutico mexicano. I: metronidazol
1983
·
Álvaro Alcántara López
, Carmen Ruiz García
, et al.
·
Revista de la Sociedad Química de México
Show more works
View as search
Works count:
17
Citation count:
779
H-index:
10
I10-index:
10
Year
Topic
Type